Almasry Pharmacy

Avipiravir 200 Mg 40 Tablets

Short Description:
Avipiravir 200 mg 40 tablets by Eva Pharma is a prescription antiviral medicine containing favipiravir, used under medical supervision for specific RNA viral infections. It works by inhibiting viral RNA polymerase, helping to reduce viral replication and viral load as part of a comprehensive treatment plan.

EGP 812

Out of Stock
delivery-iconDelivery to governorates within 3-4 working days
refund-iconEasy returns within 14 days
Specifications
SKUISG000386
BrandAvipiravirLink Icon
Categories
Medication & Treatments
Color
Luscious Blackberry
Concentrations
200 Mg
Shop by ConcernsCOVID-19Link Icon, InfluenzaLink Icon, Viral InfectionsLink Icon
Gender
Neutral
Shop By GoalsBacterial ControlLink Icon, Insomnia ReliefLink Icon
Imported Or LocalLocal
Ingredient
Favipiravir
UPC
6224010273269
Product Form
Tablets
Specialty
Clinically Tested
Prescription only
Sub Categories
Anti Viral
Unit Count
40 Tablets
Warning
Keep Out of Reach of Children
Contraindicated in pregnancy
May affect liver function
Use under medical supervision
About the product

Avipiravir 200 Mg 40 Tablets

Description:

Avipiravir 200 mg 40 tablets is a prescription antiviral medicine containing favipiravir, developed by Eva Pharma, used in the management of certain RNA viral infections under medical supervision. Favipiravir is a purine nucleoside analogue that inhibits viral RNA-dependent RNA polymerase, helping to reduce viral replication and viral load in the body. It is typically used in hospital or controlled clinical settings as part of a comprehensive treatment plan for specific viral diseases, according to national and international treatment guidelines. This product is intended for adult patients only and must be used strictly as directed by a specialist physician.


Indications:

  • Used as an antiviral medication for the treatment of specific RNA viral infections as determined by a physician.
  • May be included in treatment protocols for influenza A and B infections when recommended by health authorities and the treating doctor.
  • Has been investigated in the management of severe viral illnesses such as avian influenza and emerging viral infections (e.g. Ebola virus, Lassa virus, and COVID-19) under controlled clinical conditions and official guidelines.
  • Indications, dosing, and duration are determined by national protocols and the treating infectious disease or chest specialist.

Active Ingredients / Key Components:

  • Favipiravir – 200 mg per film-coated tablet.
  • Other excipients (tablet core and coating agents, stabilizers, etc.) – exact composition and concentrations , please check the product leaflet or the manufacturer’s official website; please refer to the official package insert for full excipient list.

Dosage & Administration / How to Use:

  • Avipiravir 200 mg is for oral use only and must be taken exactly as prescribed by your doctor.
  • Typical regimens for favipiravir in various viral infections may involve a higher loading dose on the first day followed by lower maintenance doses on subsequent days; however, the exact dose, frequency, and duration vary by indication and national protocol and must not be self-determined.
  • Tablets are usually swallowed whole with a sufficient amount of water. Do not crush or chew unless your doctor or pharmacist specifically advises otherwise.
  • Can generally be taken with or without food, but taking with food may help reduce gastrointestinal discomfort. Follow your doctor’s instructions.
  • If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed dose. Contact your doctor for guidance.
  • Do not stop treatment early or change the dose without consulting your healthcare provider, even if you feel better.

Clinical Benefits:

  • Helps inhibit viral replication by blocking RNA-dependent RNA polymerase, thereby reducing viral load in the body.
  • Supports faster control of certain RNA viral infections when used early and appropriately as part of a complete treatment regimen.
  • May help shorten the duration and severity of symptoms associated with susceptible viral infections, as directed by treatment protocols.
  • Provides a therapeutic option in cases where standard antivirals (such as neuraminidase inhibitors for influenza) may be less effective or not suitable, according to physician judgment.

Warnings & Contraindications:

  • Use only under the supervision of a qualified physician and according to official treatment guidelines. Self-medication is strictly not recommended.
  • Contraindicated in patients with known hypersensitivity or allergy to favipiravir or any of the excipients in the formulation.
  • Favipiravir has potential teratogenic effects (may harm an unborn baby). It is generally contraindicated during pregnancy. Women of childbearing potential must use effective contraception during treatment and for a period after the last dose as directed by their doctor.
  • Men receiving favipiravir may also be advised to use effective contraception during treatment and for a specified period after treatment completion, as recommended by their healthcare provider.
  • Use with caution in patients with liver impairment or a history of liver disease; liver function tests may be required before and during treatment.
  • Use with caution in patients with kidney impairment; dose adjustments may be necessary according to physician assessment.
  • Inform your doctor about all other medications, supplements, or herbal products you are taking to avoid potential drug interactions.
  • Consult your doctor before use if you are pregnant, planning to become pregnant, or breastfeeding. Breastfeeding may need to be discontinued during treatment based on medical advice.
  • Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision and official indication.
  • Keep out of reach of children.

Side Effects:
  • Common side effects may include nausea, vomiting, diarrhea, abdominal discomfort, or decreased appetite.
  • Laboratory abnormalities such as elevated liver enzymes (ALT, AST), increased uric acid levels, or changes in blood cell counts may occur; periodic blood tests may be required.
  • Headache, dizziness, or fatigue have been reported with favipiravir use in some patients.
  • Serious side effects may include severe allergic reactions (rash, itching, swelling of the face or throat, difficulty breathing), marked liver dysfunction, or severe gastrointestinal symptoms. Seek immediate medical attention if these occur.
  • If you experience any unusual symptoms or side effects, contact your doctor or pharmacist promptly for advice.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at the temperature conditions specified on the original packaging and protect from excessive heat and moisture.


Specifications:
  • Active ingredient: favipiravir 200 mg per film-coated tablet.
  • Form: film-coated oral tablets.
  • Pack size: 40 tablets per pack.
  • Intended use: prescription antiviral medicine for adults, as directed by a physician.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.

Product Reviews

Overall Rating
Customer Reviews
No reviews yet
TelegramWhatsApp